Author:
Musco Shaina,Ruekert Laura,Myers Jaclyn,Anderson Dennis,Welling Michael,Cunningham Elizabeth Ann
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Pharmacology (medical),Psychiatry and Mental health
Reference61 articles.
1. Early initiation of long-acting injectable antipsychotic treatment is associated with lower hospitalization rates and healthcare costs in patients with schizophrenia: real-world evidence from US claims data;Curr Med Res Opin,2019
2. Earlier versus later augmentation with an antipsychotic medication in patients with major depressive disorder demonstrating inadequate efficacy in response to antidepressants: a retrospective analysis of US claims data;Adv Ther,2018
3. Treatment patterns, health care resource utilization, and spending in Medicaid beneficiaries initiating second-generation long-acting injectable agents versus oral atypical antipsychotics;Clin Ther,2017
4. Model of Management (Mo.Ma) for the patient with schizophrenia: crisis control, maintenance, relapse prevention, and recovery with long-acting injectable antipsychotics (LAIs);Riv Psichiatr,2016
5. Antipsychotic adherence over time among patients receiving treatment for schizophrenia: a retrospective review;J Clin Psychiatry,2006
Cited by
17 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献